Clene Inc. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CLNNW and buy or sell other stocks, ETFs, and their options commission-free!

About CLNNW

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington, MBA
CEORobert Dee Etherington, MBA
Employees
—
Employees—
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
—
Employees—

CLNNW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
15.42K
Average volume15.42K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.05
52 Week high$0.05
52 Week low
$0.0013
52 Week low$0.0013

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.